• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMBLEM S-ICD; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMBLEM S-ICD; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number A209
Device Problems Signal Artifact/Noise (1036); Incorrect, Inadequate or Imprecise Result or Readings (1535); Failure to Convert Rhythm (1540); Failure to Sense (1559); Low impedance (2285)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/24/2022
Event Type  Injury  
Event Description
It was reported that at a routine subcutaneous implantable defibrillator (s-icd) device replacement procedure for normal battery depletion, this device was implanted and with the automatic screening tool (ast), was programmed to the same sensing vector as the former device.However, when the physician performed an induction test, the shock was unable to convert the induced ventricular fibrillation (vf).Additionally, the real time internal device electrocardiogram (egm) displayed a flat line showing a lack of sensing.This was followed by high amplitude non-cardiac noisy signals.Because the patient was still in vf, the patient was externally shocked to convert their arrhythmia.The testing result for the induced shock revealed an impedance measurement of 1 ohm.The device was able to interrogated via telemetry and the physician noted an unspecified red alert message.Because there were no additional replacement devices available, the physician turned off the shock therapy and the patient was hospitalized.A surgical replacement procedure is anticipated, but has not yet been performed.At this time, this s-icd device remains implanted and no additional adverse effects were reported.
 
Event Description
It was reported that at a routine subcutaneous implantable defibrillator (s-icd) device replacement procedure for normal battery depletion, this device was implanted and with the automatic screening tool (ast), was programmed to the same sensing vector as the former device.However, when the physician performed an induction test, the shock was unable to convert the induced ventricular fibrillation (vf).Additionally, the real time internal device electrocardiogram (egm) displayed a flat line showing a lack of sensing.This was followed by high amplitude non-cardiac noisy signals.Because the patient was still in vf, the patient was externally shocked to convert their arrhythmia.The testing result for the induced shock revealed an impedance measurement of 1 ohm.The device was able to interrogated via telemetry and the physician noted an unspecified red alert message.Because there were no additional replacement devices available, the physician turned off the shock therapy and the patient was hospitalized.A few days later, the physician surgically explanted and replaced the entire s-icd system to resolve the event.No additional adverse effects were reported.The system is expected to be returned for analysis, but has not yet been received.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a visual inspection of the device noted an arc mark on the titanium case.Arcing damage like that seen with this device is consistent with an attempt to deliver therapy through a shorted lead system, which may cause internal damage to the circuitry.Based on inspection and analysis of this device, evidence indicates the device was damaged after delivering a shock through a shorted defibrillation electrode.
 
Event Description
It was reported that at a routine subcutaneous implantable defibrillator (s-icd) device replacement procedure for normal battery depletion, this device was implanted and with the automatic screening tool (ast), was programmed to the same sensing vector as the former device.However, when the physician performed an induction test, the shock was unable to convert the induced ventricular fibrillation (vf).Additionally, the real time internal device electrocardiogram (egm) displayed a flat line showing a lack of sensing.This was followed by high amplitude non-cardiac noisy signals.Because the patient was still in vf, the patient was externally shocked to convert their arrhythmia.The testing result for the induced shock revealed an impedance measurement of 1 ohm.The device was able to interrogated via telemetry and the physician noted an unspecified red alert message.Because there were no additional replacement devices available, the physician turned off the shock therapy and the patient was hospitalized.A few days later, the physician surgically explanted and replaced the entire s-icd system to resolve the event.No additional adverse effects were reported.The system was received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBLEM S-ICD
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14640192
MDR Text Key293627300
Report Number2124215-2022-20383
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110042/S043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/29/2024
Device Model NumberA209
Device Catalogue NumberA209
Device Lot Number161603
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/24/2022
Initial Date FDA Received06/08/2022
Supplement Dates Manufacturer Received06/10/2022
10/12/2022
Supplement Dates FDA Received06/24/2022
11/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/11/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient SexMale
-
-